Skip to Content
Merck
  • Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.

Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.

Xenobiotica; the fate of foreign compounds in biological systems (2014-11-05)
Takashi Koyanagi, Yasuharu Nakanishi, Norie Murayama, Yoshiyuki Yamaura, Kanami Ikeda, Koji Yano, Shotaro Uehara, Masahiro Utoh, Soonih Kim, Yasuhiro Uno, Hiroshi Yamazaki
ABSTRACT

1. Pharmacokinetics of human cytochrome P450 probes (caffeine, racemic warfarin, omeprazole, metoprolol and midazolam) were investigated after single intravenous and oral administrations at doses of 0.20 and 1.0 mg kg(-1), respectively, in combination to three young (3-year-old) and three aged (16-year-old) cynomolgus monkeys. 2. The plasma concentrations of caffeine and R-/S-warfarin decreased slowly in a monophasic manner, but those of omeprazole, metoprolol and midazolam decreased rapidly, in a similar manner to those as reported for pharmacokinetics in humans. 3. The mean maximum concentrations of R- and S-warfarin (4.6 and 3.7 µg/mL, respectively) in aged monkeys after oral administration were significantly higher than those in young monkeys (3.3 and 2.7 µg/mL). The mean clearance (CL) values of midazolam in aged monkeys (9.5 mL/min/kg) were significantly lower than those in young monkeys (13 mL/min/kg). 4. Individual intrinsic CL values for omeprazole (r = 0.29) and metoprolol (r = 0.30) of individual monkey livers were inversely correlated with their ages significantly (p < 0.05) in liver microsomes prepared from 55 cynomolgus monkeys. 5. These results suggest that cynomolgus monkeys could be a good model for humans, especially with particular characteristics in reduced CLs of some human P450 substrates by aging.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Theobromine, ≥98.0%
Supelco
Warfarin, analytical standard
Sigma-Aldrich
Theophylline, anhydrous, ≥99%, powder
Supelco
Warfarin, PESTANAL®, analytical standard
Supelco
Theophylline, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Melting point standard 235-237°C, analytical standard
Theophylline, European Pharmacopoeia (EP) Reference Standard
USP
Warfarin, United States Pharmacopeia (USP) Reference Standard
USP
Theophylline, United States Pharmacopeia (USP) Reference Standard
Caffeine for system suitability, European Pharmacopoeia (EP) Reference Standard
Supelco
Theobromine, analytical standard
Sigma-Aldrich
Caffeine, anhydrous, tested according to Ph. Eur.
Sigma-Aldrich
Caffeine, anhydrous, 99%, FCC, FG
Sigma-Aldrich
Caffeine, meets USP testing specifications, anhydrous
Sigma-Aldrich
1,7-Dimethylxanthine, ~98%, solid
Sigma-Aldrich
Omeprazole, solid
Sigma-Aldrich
Caffeine, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Caffeine, BioXtra
Sigma-Aldrich
Caffeine, powder, ReagentPlus®
Sigma-Aldrich
β-D-Allose, rare aldohexose sugar
Supelco
Mettler-Toledo Calibration substance ME 18872, Caffeine, traceable to primary standards (LGC)
USP
Caffeine melting point standard, United States Pharmacopeia (USP) Reference Standard
Supelco
Caffeine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Caffeine, Pharmaceutical Secondary Standard; Certified Reference Material
Omeprazole for peak identification, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Caffeine, SAJ special grade, ≥98.5%
Supelco
Caffeine Melting Point Standard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Omeprazole, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Omeprazole, United States Pharmacopeia (USP) Reference Standard
Caffeine, European Pharmacopoeia (EP) Reference Standard